54327

HIV/HCV COINFECTION RATE IN PATIENTS REGISTERED IN THE MUNICIPAL HIV PROGRAM IN BRAGANÇA PAULISTA/SP IN 2015

BRENO HATTORI 1 ; ELISA BASSO DONATTI 1 ; GISLAINE CRISTINA MOREIRA 1 ; GUSTAVO BALDOVE BETTONI 1 ; JOSÉ RIBAMAR BORGES MENDES 1 ; MARIANA QUILICI BACCI 2 ; PEDRO CARPINI DE OLIVEIRA 1
Download
Favorite this paper

Abstract Introduction and Objective. HCV is a major cause of hepatic disease worldwide spreaded. It usually turns to chronic forms either subclinic or clinic. Around 3% of global population is infected and up to 30% of them are coinfected with HIV, determining worse prognostic. Prevalence of HCV is expected to reduce drastically with the recent development of new drugs such as Daclatasvir, Sofosbuvir and Simeprevir in spite of previous PEG-IFN and riboflavin. To assure accurate data to compare with the upcoming evidences, this study organizes epidemiological data until October 2015 concearning HCV coinfection in patients following HIV treatment in Bragança Paulista/SP. Method. The data was collected from medical records from the venereal deseases municipal center. Results and Conclusion. Among 403 diagnosed HIV patients, 22 were HCV coinfected, of which 6 were treated with the previous drugs, with 50% cure rate. The coinfection rate founded is below the national average and the success of the treatment observed is not satisfactory. Further data will be provided about the new treatment which will be adopted in 2016.